When to use polymixin (Polymyxin B) eye drops?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Polymyxin B Eye Drops: Indications and Usage

Polymyxin B eye drops should be used for bacterial conjunctivitis and as prophylaxis for bacterial keratitis following corneal abrasion or trauma, particularly when treatment is started within 24 hours of the injury. 1

Primary Indications

  • Polymyxin B eye drops (typically combined with trimethoprim) are indicated for the treatment of bacterial conjunctivitis 2, 3
  • They serve as prophylactic treatment following corneal abrasion to prevent bacterial keratitis, especially when started within 24 hours of injury 1
  • Polymyxin B combinations are effective against both gram-positive and gram-negative pathogens commonly causing ocular surface infections 2

Specific Clinical Scenarios

Bacterial Conjunctivitis

  • Polymyxin B (typically combined with trimethoprim) is effective for bacterial conjunctivitis with clinical cure rates of 83-95% 4, 3
  • The standard dosing regimen is one drop in the affected eye(s) every three hours (maximum of 6 doses per day) for 7-10 days 5
  • Pediatric patients over two months of age can receive the same dosing regimen as adults 5

Corneal Abrasions

  • Prophylactic topical antibiotics including polymyxin B combinations are recommended following corneal abrasion to prevent ulceration 1
  • For contact lens wearers with corneal abrasions, broad-spectrum antibiotics like polymyxin B combinations are particularly important due to higher infection risk 1, 6

Limitations and Considerations

  • Polymyxin B eye ointments have limited corneal penetration compared to drops, making them more suitable for adjunctive therapy or bedtime use in less severe cases 1
  • For central or severe keratitis, fluoroquinolones are generally preferred over polymyxin B combinations due to better tissue penetration 1
  • Chronic use of prophylactic antibiotics including polymyxin B may promote growth of resistant organisms 1
  • Hypersensitivity reactions to polymyxin B can range from local effects to generalized reactions including erythema, itching, urticaria, skin rash, and anaphylaxis 7

Comparative Efficacy

  • Newer fluoroquinolones like moxifloxacin may work faster than polymyxin B combinations, with one study showing 81% resolution at 48 hours with moxifloxacin versus 44% with polymyxin B/trimethoprim 8
  • However, trimethoprim-polymyxin B has been shown to be significantly better than chloramphenicol in reducing signs and symptoms of bacterial conjunctivitis 9
  • For bacterial keratitis, single-drug therapy using a fluoroquinolone has been shown to be as effective as combination therapy utilizing fortified antibiotics 1

Special Populations

  • Polymyxin B combinations have been shown to be safe and effective in pediatric patients over two months of age 5
  • When combined with steroids (as in some formulations), caution is needed in patients with a history of herpes simplex, as steroids may exacerbate viral eye infections 7

Monitoring and Follow-up

  • Regular follow-up is necessary to monitor healing and detect early signs of infection 6
  • If using a polymyxin B formulation containing steroids, intraocular pressure should be routinely monitored if used for 10 days or longer 7
  • Cross-hypersensitivity to other aminoglycosides can occur, and treatment should be discontinued if hypersensitivity develops 7

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.